magnesium laevo-aspartate hydrochloride trihydrate
magnesium L-aspartate hydrochloride (1:1:1)
Identification
| Name | magnesium laevo-aspartate hydrochloride trihydrate |
| IUPAC | magnesium; 2-aminobutanedioate; hydron; chloride |
| CAS Number | 28184-71-6 |
| FDA UNII | 5LK942W2PC |
| Molecular Formula | C4 H6 Cl Mg N O4 |
| Molecular Weight | 191.85262000 |
Regulatory
Physical Properties
| Appearance | white powder (est) |
| Assay | 95.00 to 100.00 |
| Food Chemicals Codex Listed | No |
| Boiling Point | 264.00 to 265.00 °C. @ 760.00 mm Hg (est) |
| Vapor Pressure | 0.002890 mmHg @ 25.00 °C. (est) |
| Flash Point | 236.00 °F. TCC ( 113.50 °C. ) (est) |
| logP (o/w) | -0.669 (est) |
| Soluble in | water |
No sensory data available
Safety Information
| Oral/Parenteral Toxicity | oral-rat LD50 4850 mg/kg |
| Dermal Toxicity | subcutaneous-rat LD50 1950 mg/kg |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | nutrient supplements |
| Recommendation for magnesium laevo-aspartate hydrochloride trihydrate usage levels up to | not for fragrance use. |
| Recommendation for magnesium laevo-aspartate hydrochloride trihydrate flavor usage levels up to | not for flavor use. |
BOC Sciences
Best of Chemicals Supplier
Quality supplier of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecul...
Potential Uses
Natural Occurrence
Synonyms
(L-
aspartato(2-)-N,O(sup 1),O(sup 4))chloromagnesate(1-) hydrogen (T-4) trihydrate
magnesate(1-), (L-aspartato(2-)-N,O(sup 1),O(sup 4))chloro-, hydrogen, (T-4), trihydrate
magnesium L-aspartate hydrochloride (1:1:1)
magnesium L-aspartate hydrochloride trihydrate
magnesium laevo-aspartate hydrochloride (1:1:1)
magnesium; 2-aminobutanedioate; hydron; chloride
PubMed:
Interactions between iron(III)-hydroxide polymaltose complex and commonly used medications / laboratory studies in rats.
PubMed:
Interactions between iron(III)-hydroxide polymaltose complex and commonly used drugs / simulations and in vitro studies.
PubMed:
A preliminary, controlled investigation of magnesium L-aspartate hydrochloride for illicit cocaine and opiate use in methadone-maintained patients.
PubMed:
Therapeutic availability of iron administered orally as the ferrous gluconate together with magnesium-L-aspartate hydrochloride.
PubMed:
Potentiation of magnesium-deficiency-induced foetotoxicity by concomitant iron deficiency and its prevention by adequate supply via drinking water.
PubMed:
Increase of streptozocin toxicity by magnesium deficiency in the diabetic rat model.
PubMed:
In vitro mechanisms and models of gentamicin nephrotoxicity.